Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Plunkett Research, Ltd.
$99.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medtronic Inc Reaffirms FY 2014 Guidance-Conference Call


Tuesday, 19 Nov 2013 08:00am EST 

Medtronic Inc announced that it continue to expect constant currency revenue growth of 3% to 4% remains reasonable for the fiscal 2014 and continue to expect fiscal 2014 non-GAAP diluted earnings per share (EPS) in the range of $3.80 to $3.85. The Company reported revenue of $16.590 billion in fiscal 2013. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.83 for fiscal 2014. 

Company Quote

63.38
0.67 +1.07%
23 Jul 2014